Bimatoprost/Timolol Versus Travoprost/Timolol

The purpose of this study is to compare 2 fixed combination medications in intraocular pressure lowering.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kasr El Aini Hospital

Cairo, Egypt

About this study

PURPOSE: To compare the efficacy of bimatoprost/timolol (BTFC) or travoprost/timolol (TTFC) fixed combinations on intraocular pressure (IOP) reduction in an Egyptian population.

METHODS: Patients with primary open angle glaucoma (POAG) were randomized to receive either BTFC or TTFC. IOPs were measured at baseline, 2 weeks, and 1, 2, 4, and 6 months. The primary outcome measures were the mean change in IOP from baseline

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Glaucoma

Exclusion criteria

No other ocular diseases

Treatment and study plan

Ganfort

Drug

Bimatoprost/Timolol fixed combination

Other names: Bimatoprost/Timolol vs Travoprost/Timolol fixed combination

Duotrav

Drug

Fixed combination of Travoprost and Timolol

Primary outcomes

Percentage of drop of intraocular pressures from baseline.

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Kasr El Aini Hospital

Other

Registry information

Official study title

Bimatoprost/Timolol Versus Travoprost/Timolol Fixed Combinations in an Egyptian Population: A Hospital-Based Prospective Randomized Study

Important dates

Study start: 2011
Primary completion: 2011
Study completion: 2011
First posted: Mar 2, 2012
Registry last updated: Mar 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed